Literature DB >> 15931342

Genotyping Parkinson disease-associated mitochondrial polymorphisms.

Yiguo Jiang1, Tammy Ellis, Anne R Greenlee.   

Abstract

OBJECTIVE: The purpose of this study was to establish a system for rapidly detecting single nucleotide polymorphisms (SNPs) in mitochondrial DNA (mtDNA) using hybridization probes and melting temperature (T(m)) analysis. This technology should prove useful for population-based studies on the interaction between genetic factors and environmental exposures and the risk of Parkinson disease (PD).
METHODS: Mitochondrial DNA (mtDNA) was extracted from whole blood. Rapid polymerase chain reaction (PCR) and melting curve analyses were performed with primers and fluorochrome-labeled probes on a LightCycler (Roche Molecular Biochemical, Mannheim, Germany). Genotyping of 10 SNPs in 15 subjects was based on the analysis of allele-specific T(m) of detection probes. The results of melting curve analyses were verified by sequencing all 150 PCR products.
RESULTS: Real-time monitoring showed optimal PCR amplification of each mtDNA fragment. The nucleotide changes at positions 1719, 4580, 7028, 8251, 9055, 10398, 12308, 13368, 13708, and 16391 from wild-type to mutant genotype resulted in 6.51, 8.29, 3.26, 7.82, 4.79, 2.84, 2.73, 9.04, 8.53, and 9.52 degrees C declines in T(m) of the detection probes, respectively. Genotyping of all 150 samples was verified by 100% correspondence with the results of sequencing. Fourteen subjects were haplogrouped by combining results for all 10 SNPs.
CONCLUSION: A rapid and reliable detection system for identifying mitochondrial polymorphisms and haplotypes was developed based on hybridization probe technology. This method may be suitable for mitochondrial genotyping of samples from large-scale epidemiology studies, and may prove useful for exploring the molecular etiopathogenesis of PD, identifying markers of genetic susceptibility, and protecting susceptible individuals from PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15931342      PMCID: PMC1069078          DOI: 10.3121/cmr.2.2.99

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  40 in total

1.  DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR.

Authors:  N von Ahsen; M Oellerich; E Schütz
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

2.  A simultaneous LightCycler detection assay for five genetic polymorphisms influencing drug sensitivity.

Authors:  Masahiro Hiratsuka; Kaori Narahara; Yukinaga Kishikawa; Samar Ismail Hamdy; Naomi Endo; Yasuyuki Agatsuma; Masaki Matsuura; Tomoko Inoue; Yoshihisa Tomioka; Michinao Mizugaki
Journal:  Clin Biochem       Date:  2002-02       Impact factor: 3.281

Review 3.  DNA probes: applications of the principles of nucleic acid hybridization.

Authors:  J G Wetmur
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

4.  Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients.

Authors:  M D Brown; J M Shoffner; Y L Kim; A S Jun; B H Graham; M F Cabell; D S Gurley; D C Wallace
Journal:  Am J Med Genet       Date:  1996-01-22

5.  Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes.

Authors:  M R Gätke; J Viby-Mogensen; J R Bundgaard
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

6.  Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.

Authors:  M J Torres; A Criado; J C Palomares; J Aznar
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation.

Authors:  D K Simon; S M Pulst; J P Sutton; S E Browne; M F Beal; D R Johns
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

8.  Hydrocarbon exposure and Parkinson's disease.

Authors:  G Pezzoli; M Canesi; A Antonini; A Righini; L Perbellini; M Barichella; C B Mariani; F Tenconi; S Tesei; A Zecchinelli; K L Leenders
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

9.  Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.

Authors:  Joelle M van der Walt; Kristin K Nicodemus; Eden R Martin; William K Scott; Martha A Nance; Ray L Watts; Jean P Hubble; Jonathan L Haines; William C Koller; Kelly Lyons; Rajesh Pahwa; Matthew B Stern; Amy Colcher; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Christopher G Goetz; Gary W Small; Frank Mastaglia; Jeffrey M Stajich; Adam C McLaurin; Lefkos T Middleton; Burton L Scott; Donald E Schmechel; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Am J Hum Genet       Date:  2003-02-28       Impact factor: 11.025

Review 10.  Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Authors:  Y Ben-Shlomo; K Sieradzan
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

View more
  2 in total

1.  Genetic Diversity Analysis of the Chinese Daur Ethnic Group in Heilongjiang Province by Complete Mitochondrial Genome Sequencing.

Authors:  Mansha Jia; Qiuyan Li; Tingting Zhang; Bonan Dong; Xiao Liang; Songbin Fu; Jingcui Yu
Journal:  Front Genet       Date:  2022-06-21       Impact factor: 4.772

2.  Analysis of mitochondrial DNA variations in Indian patients with congenital cataract.

Authors:  Mascarenhas Roshan; Shama Prasada Kabekkodu; Pai H Vijaya; Kamath Manjunath; Jochen Graw; P M Gopinath; Kapeattu Satyamoorthy
Journal:  Mol Vis       Date:  2012-01-24       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.